sendolor 20 mg/ml infusionslösung
sendolor 10 mg/ml infusionslösung
amekrin 75 mg/1,5 ml koncentrat och vätska till koncentrat till infusionsvätska, lösning
amsalyo 75 mg pulver till koncentrat till infusionsvätska, lösning
tepadina 15mg powder for concentrate for solution for infusion vials
adienne pharma & biotech - thiotepa - powder for solution for infusion - 15mg
tepadina 100mg powder for concentrate for solution for infusion vials
adienne pharma & biotech - thiotepa - powder for solution for infusion - 100mg
kefurox 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial
eurocept b.v. - cefuroxime sodium 1500 mg - powder for suspension for infusion; powder for suspension for injection; powder for solution for injection/infusion - cefuroxime
kefurox 750 mg inj./inf. sol. (pwdr.) i.m./i.v. vial
eurocept b.v. - cefuroxime sodium - eq. cefuroxime 750 mg - powder for solution for injection/infusion - cefuroxime
thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastic agents - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients
esketiv 25 mg/ml injektionslösung